| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2710c6b259267c8ad1cbe2c1e8a4bdb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a2f77c5b17dee8cb1d10dd7a070ee10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd547d7b9da097dc3d0543292ff7ec6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92546d1a228cd6604fe3b4980fc70692
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c252bb19c94095b6b994ba422ac830a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43527
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-002 |
| filingDate |
2011-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f26fa7d07782c36cfdbf49f508f939a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c12d1890a2137ee7ee286e0c1b4b1575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1e55826afe18eacc242ecf6ac290156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca41956d9407d4a60d8747b2b9dab2a9 |
| publicationDate |
2015-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9085634-B2 |
| titleOfInvention |
Vaccine composition for controlling ectoparasite infestations |
| abstract |
The present invention relates to the use of a peptide of P0 ribosomal protein in the manufacture of a vaccine composition to control of ectoparasite infestations and therefore the transmission of their associated pathogens. This peptide is located between 267 and 301 amino acids of the P0 protein, and can be obtained by recombinant means or by chemical synthesis. This peptide can be fused to a carrier protein or peptide, or an immuno-carrier and be included in an oily formulation. The formulations comprising the peptide vaccine confer protection against ticks and ectoparasites known as “sea lice” without generating autoimmunity in the host organism. Among these ticks may be mentioned species as Rhipicephalus microplus, Rhipicephalus sanguineus and Ixodes scapularis , and between sea lice are those of the Caligus and Lepeophtheirus genera. |
| priorityDate |
2010-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |